Central hemodynamics and arterial stiffness in adult humans depend on the conditions of early development in the Northern Kola Peninsula

2016 ◽  
Vol 42 (2) ◽  
pp. 150-155 ◽  
Author(s):  
V. N. Melnikov ◽  
I. Yu. Suvorova ◽  
N. K. Belisheva
2014 ◽  
Vol 167 (2) ◽  
pp. 141-149.e2 ◽  
Author(s):  
William E. Moody ◽  
Laurie A. Tomlinson ◽  
Charles J. Ferro ◽  
Richard P. Steeds ◽  
Patrick B. Mark ◽  
...  

Hypertension ◽  
2017 ◽  
Vol 70 (6) ◽  
pp. 1283-1290 ◽  
Author(s):  
Snigdha Jain ◽  
Indira Gurubhagavatula ◽  
Raymond Townsend ◽  
Samuel T. Kuna ◽  
Karen Teff ◽  
...  

2021 ◽  
Vol 35 (S1) ◽  
Author(s):  
McKenna Tharpe ◽  
Alex Barnett ◽  
Zach Hutchison ◽  
Braxton Linder ◽  
Andreas Kavazis ◽  
...  

2021 ◽  
Vol 53 (8S) ◽  
pp. 78-78
Author(s):  
Meral N. Culver ◽  
Alexander H.K. Montoye ◽  
Nathan K. McMillan ◽  
Brett L. Cross ◽  
Bryan L. Riemann ◽  
...  

Thyroid ◽  
2016 ◽  
Vol 26 (6) ◽  
pp. 779-784 ◽  
Author(s):  
Esben Laugesen ◽  
Emil Moser ◽  
Tanja Sikjaer ◽  
Per Løgstrup Poulsen ◽  
Lars Rejnmark

2020 ◽  
Vol Volume 13 ◽  
pp. 3289-3299
Author(s):  
Rosaria Del Giorno ◽  
Christos Ceresa ◽  
Sofia Gabutti ◽  
Chiara Troiani ◽  
Luca Gabutti

2020 ◽  
Vol 2020 ◽  
pp. 1-8
Author(s):  
Akshyaya Pradhan ◽  
Pravesh Vishwakarma ◽  
Monika Bhandari ◽  
Rishi Sethi ◽  
Varun Shankar Narain

Background. Central aortic blood pressure (CABP) indices, central hemodynamics, and arterial stiffness are better predictors of cardiovascular events as compared with brachial cuff pressure measurements alone. The present study is aimed at assessing the effects of different antihypertensive drug combination regimens involving renin-angiotensin-aldosterone system (RAAS) inhibitors on CABP indices in Indian patients with hypertension. Methods. This was a cross-sectional, single-center study conducted in patients treated for hypertension for >6 weeks using different treatment regimens involving the combination of RAAS inhibitors with drugs from other classes. CABP indices, vascular age, arterial stiffness, and central hemodynamics were measured in patients using the noninvasive Agedio B900 device (IEM, Stolberg, Germany) and compared between different treatment regimens. Results. A total of 199 patients with a mean age of 54.22±10.15 years were enrolled, where 68.8% had hypertension for over three years and 50.25% had their systolic blood pressure SBP<140 mmHg. Combination treatment with angiotensin II receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEIs) was given to 77.9% and to 20.1% patients, respectively. The mean vascular age was higher than the actual age (58.13±12.43 vs. 54.22±10.15, p=0.001). The SBP and diastolic blood pressure (DBP) levels in patients treated with ACEI-based combinations were lower than those in patients treated with ARB-based combinations (p<0.05). The mean central pulse pressure amplification, augmentation pressure, and augmentation index were lower in patients treated with ACEI-based combinations than those treated with other treatments (p=0.001). In a subgroup analysis, patients given perindopril and calcium channel blockers (CCBs) or diuretics had significantly lower CABP and pulse wave velocity than those given other treatments (p<0.05). A total of 6.5% patients experienced any side effects. Conclusion. The majority of central hemodynamic parameters, including vascular age, were found to improve more effectively in patients treated with ACEIs than with ARBs. Our results indicate a gap between routine clinical practice and evidence-based guidelines in Indian settings and identify a need to reevaluate the current antihypertensive prescription strategy.


2019 ◽  
Vol 177 ◽  
pp. 108592 ◽  
Author(s):  
Sierra N. Clark ◽  
Alexandra M. Schmidt ◽  
Ellison M. Carter ◽  
James J. Schauer ◽  
Xudong Yang ◽  
...  

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
D Messiha ◽  
L Halfmann ◽  
O Azizy ◽  
M Steinmetz ◽  
T Rassaf ◽  
...  

Abstract Background Peripheral artery disease (PAD) is a major manifestation of atherosclerosis and a risk factor for morbidity and mortality. PAD itself is associated with increased arterial stiffness with impact on cardiac functions. Previous studies have demonstrated that augmentation index (AIx) and central blood pressure (CBP) correlate with increased cardiovascular mortality. This mechanism has been described as arterio-ventricular (AV) coupling with altered ventricular afterload and a depressed ventricular function, measured by global longitudinal strain (GLS). The impact of PAD-related endovascular treatment on arterial stiffness, central hemodynamics and potential impact on AV coupling has not been elucidated until now. Purpose Aim of the study was to investigate, if endovascular treatment of PAD improves cardiac function via enhanced central hemodynamics and AV coupling. Methods To this aim 77 patients with known symptomatic PAD who underwent interventions in the iliac and femoropopliteal arteries were included in a cross-sectional study. AIx, CBP and GLS were determined using dedicated waveform analysis and echocardiography before and after endovascular treatment. Results Mean age was 65.1±10.4 years with 66.2% male patients. Symptoms were classified by Fontaine classification (stage IIb 80.7%, stage III 5.8% and stage IV 13.5%). Iliac vessel intervention was performed in 16 and femoropopliteal intervention in 61 cases. A stentless approach was feasible in 55 patients with DCB treatment and atherectomy. After endovascular treatment, peripheral perfusion was enhanced (ABI 0.45±0.6 vs 0.81±0.5, p&lt;0.0001). Moreover, central hemodynamics were improved (AIX 33.7±3% vs 27.9±2%, p=0.0008; AP 17.8±2 mmHg vs 14.0±2 mmHg, p=0.0004; central PP 52.4±6 mmHg vs 46.4±6 mmHg, p=0.0001). Impressively, left ventricular function was also significantly improved (GLS −15.7±2.3% vs −17.1±2.8%, p=0.005) with an improvement in AV coupling (PWV/GLS ratio −0.58m/sec% vs −0.56m/sec%, p&lt;0.01). Conclusion Our results demonstrate that endovascular treatment of the peripheral vessels is associated with an improvement of central hemodynamics and left ventricular function via enhanced AV coupling. These prognostic relevant markers of cardiovascular disease could point to an overall potential mortality benefit through PAD treatment. Further investigation of the underlying mechanisms of AV coupling in the setting of endovascular treatment of PAD with impact on cardiovascular mortality is needed in this high-risk population. Funding Acknowledgement Type of funding source: None


Sign in / Sign up

Export Citation Format

Share Document